Clinical Trials | May 25, 2026
AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%
The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial
The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
Transition to a fermentation-based globally integrated CDMO platform
A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern
The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications
The new facility at Byatarayanapura introduces Karnataka’s first Elekta Unity MR-Linac technology
The company intends to file an IND submission by the end of this year and begin clinical studies in 2027
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges
Subscribe To Our Newsletter & Stay Updated
